The Institute for Research in Biomedicine (IRB Barcelona) and the European biotech company Galapagos NV, based in Belgium, have established a scientific collaboration to identify and validate a series of senolytic drug targets with potential for use in tissue repair across multiple organs. The collaboration is based on the results of a large-scale analysis of genes that potentially play a role in fibrosis, inflammation, and the ageing process.
Results from an initial analysis, performed by the Cellular Plasticity and Disease lab at IRB Barcelona, showed that these genes may participate in...
On 23 April, the exhibition of IRB Barcelona's first Artist in Residence will be launched at the Sant Pau Art Nouveau Site, and will be open until 30 June.
Rierola recreates Bosch's work of the same name with images provided by researchers.
This second art and science exhibition at this venue has been organised jointly by IRB Barcelona, the Quo Artis Foundation and the Sant Pau Art Nouveau Site.
This new technology in advanced confocal microscopy is the only one in Spain and it will accelerate the fight against cancer by facilitating innovative research projects on cell plasticity, response to treatment, and relapse.
The kick-off meeting was held on 4 and 5 March after the official start of the project on 1 March 2021.
Coordinated by IRB Barcelona, Evomet seeks to train future metastasis researchers to apply the knowledge generated in basic research to the search for therapeutic solutions.
The Banc Sabadell Foundation and IRB Barcelona have signed a collaboration agreement and announced their intention to join forces to fight cancer.
Through this agreement, the Banc Sabadell Foundation renews its commitment to the Metastasis Challenge, the call for citizen mobilisation launched by IRB Barcelona to raise social awareness of the need to promote research to stop the metastasis of different types of cancer and to stop this serious disease from killing. Metastasis is currently responsible for 90% of cancer deaths.
The programme seeks to enhance the production of new drugs through a powerful research programme in Chemical Biology that will allow the creation of a chemical biology hub in Barcelona.
By supporting the appointment of two new Junior Group Leaders, the programme has facilitated the setup of two new research groups, one at IRB Barcelona and the other at IBEC.
IRB Barcelona's commitment to talented young female scientists takes shape with the appointment of Dr. Cristina Mayor-Ruiz, who will be leading a scientific project with wide applications in patients devoted to the innovative technique of targeted protein degradation.
Funded under the Science with and for Society Programme of Horizon 2020, ENABLECARES will deliver high-level training in open science, entrepreneurship and other relevant transferable skills to young scientists in Europe.
Building on the expertise of IRB Barcelona's Innovation Department and Radboud University on entrepreneurship and Open Science, ENABLECARES will implement two training curricula in these subjects (nodes) at all four partners through co-creation and Train-the-Trainers strategies.
The ICREA Acadèmia Award allows university professors to prioritise their dedication to research for 5 years.
The Cell Signaling laboratory, headed by Dr. Eulàlia de Nadal and Dr. Francesc Posas, studies cell adaptation response to stress.
This day promotes equal access to and full participation in science for women and girls.
Outreach activities are held focused on making the work of female researchers visible and encouraging girls to have these role models.
In the context of this day, IRB Barcelona shares an example of the visibility of the women scientists: girls and boys at the Pau Casals de Gracia school (Barcelona) have named their class after the researcher Núria López-Bigas.
The 5-year research project involves 14 organisations in seven EU countries and is funded by €15 M from the EU.
The Genome Data Science lab, led by ICREA researcher Fran Supek, will analyse the evolution of ovarian tumours to develop computational models for predicting treatment resistance.